Skip to content
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Shingles by Stan Wasbin, M.D.

What would life be without a little mystery?  I often ask this rhyming question in response to the endless unknowns that riddle the field of medicine.   Herpes zoster, also known as shingles, is reactivated chickenpox.  Why would a virus residing near the spinal cord — but quiescent for decades — suddenly re-emerge to cause a painful and sometimes dangerous eruption on the body’s surface?  While science often is able to answer questions concerning “Who?  Where?  How?  and What?,”  it seems ill-equipped to answer the question “Why?”

Yet the quest to understand nevertheless prompts us to wonder “Why?”  In the case of shingles, why is this condition growing more prevalent in our country — and, at a time when a vaccine is in use to prevent attacks?   And, why does a shingles attack leave its victim with an increased risk of stroke during the next six months?  According to The Journal of the American Medical Association (June 11, 2014, p. 2263), the risk is highest in the first month after a shingles episode, when the patient is 63% more likely to suffer a stroke.

While doctors often are unable to answer why questions, we still can offer useful advice when it comes to shingles:

  • An antiviral drug (like Valtrex) can hasten the resolution of shingles, and the sooner it has begun, the stronger the effect.  Moreover, taking this drug for an acute attack of herpes zoster, confers some protection against the increased risk of stroke during the ensuing six months.
  • A single shot of the shingles vaccine, which can be given as early as 50 years of age, offers some protection against the illness, and even better protection against one of the dreaded complication of shingles:  post-herpetic neuralgia, horrible pain that persists long after the shingles rash has disappeared.

 

The information provided is for general interest only and should not be misconstrued as a diagnosis, prognosis or treatment recommendation. This information does not in any way constitute the practice of medicine, or any other health care profession. Readers are directed to consult their health care provider regarding their specific health situation. Marque Medical is not liable for any action taken by a reader based upon this information.